TrueBlue (TBI)
(Real Time Quote from BATS)
$6.40 USD
-0.06 (-0.93%)
Updated Sep 19, 2025 02:00 PM ET
2-Buy of 5 2
D Value B Growth F Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
TBI 6.40 -0.06(-0.93%)
Will TBI be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for TBI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TBI
TrueBlue (TBI) Upgraded to Buy: Here's What You Should Know
TrueBlue (TBI) Reports Q2 Loss, Misses Revenue Estimates
TBI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Insperity, Inc. (NSP) Lags Q2 Earnings and Revenue Estimates
TrueBlue (TBI) Reports Q1 Loss, Tops Revenue Estimates
Insperity, Inc. (NSP) Lags Q1 Earnings and Revenue Estimates
Other News for TBI
TBI Crossed Above 50 Day Moving Average on September 18
Is TBI likely to continue lower? Fell Below 50 Day Moving Average shows up after sliding 2.53%
Crossed Above 50 Day Moving Average appears for TBI after 2.59% move
TBI forms 20 Day Moving Average Support on September 15
Is TBI primed for upward momentum? Crossed Above 20 Day Moving Average shows up after climbing 1.87%